DOI QR코드

DOI QR Code

Anti-Obesity Effect of Eriobotrya japonica Leaves Extract on Obese Mice Induced by High-Fat Diet

비파잎 추출물이 고지방식이로 유도한 비만쥐에 미치는 항비만 효과

  • Lee, Somi (Fruit Research Institute (Jeollanamdo Agricultural Research & Extension Service)) ;
  • Park, Moonyoung (Fruit Research Institute (Jeollanamdo Agricultural Research & Extension Service)) ;
  • Kim, Ok Kyung (Department of Medical Nutrition and Research Institute of Medical Nutrition, Kyung Hee University) ;
  • Lee, Jeongmin (Department of Medical Nutrition and Research Institute of Medical Nutrition, Kyung Hee University) ;
  • Jun, Woojin (Department Food and Nutrition, Chonnam National University)
  • 이소미 (전남농업기술원 과수연구소) ;
  • 박문영 (전남농업기술원 과수연구소) ;
  • 김옥경 (경희대학교 동서의학대학원 의학영양학과) ;
  • 이정민 (경희대학교 동서의학대학원 의학영양학과) ;
  • 전우진 (전남대학교 생활과학대학 식품영양과학부)
  • Received : 2016.04.11
  • Accepted : 2016.07.05
  • Published : 2016.08.31

Abstract

This study investigated the anti-obesity effects of Eriobotrya japonica leaves extract (EJE) in a high-fat diet-induced obese mice model. For the analysis, 40 mice were randomly divided into five groups: normal diet (ND), high-fat diet group (HD), high-fat diet containing EJE 100 mg/kg b.w. (EJE-L), 500 mg/kg b.w. (EJE-H), and Garcinia cambogia extract 100 mg/kg b.w. in each AIN 93G supplement for 8 weeks as positive control. During the study period, food intake and body weight were measured separately. Body weight, serum triglyceride level, and total cholesterol levels of the EJE group were significantly lower than those of the HD and ND. Moreover, mice fed an EJE-containing high-fat diet showed decreased leptin levels compared with high-fat diet-induced obese mice. These results suggest that EJE has potential as an anti-obesity agent by reducing body weight and improving levels of triglycerides, total cholesterol, low density lipoprotein-cholesterol, and leptin in serum.

본 연구는 비파잎 추출물이 고지방식이로 유도한 비만쥐에 미치는 항비만 효과를 조사하였다. 8주 동안 고지방식이에 100 mg/kg b.w., 500 mg/kg b.w.의 비파잎 추출물을 보충한 그룹과 고지방식이군만을 제공한 그룹을 비교하였다. 비파잎 추출물은 식이섭취량에는 영향을 주지 않으면서도 고지방식이군과 비교하여 유의적으로 체중증가를 줄이고 내장지방의 축적을 억제하였다. 또한, 비파잎 추출물을 급여한 군은 고지방식이군과 비교하여 혈중 지질, 간지질의 축적, 혈중 렙틴 농도를 감소시켰다. 이상의 실험 결과로 고지방식 이와 함께 급여한 비파잎 추출물은 체중, 간 및 지방조직의 무게 감소와 더불어 혈장 지질 농도를 개선하고 혈장 렙틴농도를 감소시키므로 항비만 효과를 가진 천연 기능성 식품의 소재로써 활용 가능성이 있을 것으로 생각된다.

Keywords

References

  1. Manson JE, Skerrett PJ, Greenland P, VanItallie TB. 2004. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med 164: 249-258. https://doi.org/10.1001/archinte.164.3.249
  2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. 2001. The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 1195-1200. https://doi.org/10.1001/jama.286.10.1195
  3. Gimeno RE, Klaman LD. 2005. Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol 5: 122-128. https://doi.org/10.1016/j.coph.2005.01.006
  4. Heber D. 2010. An integrative view of obesity. Am J Clin Nutr 91: 280S-283S. https://doi.org/10.3945/ajcn.2009.28473B
  5. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 2131-2135. https://doi.org/10.1001/jama.282.22.2131
  6. Das UN. 2001. Is obesity an inflammatory condition?. Nutrition 17: 953-966. https://doi.org/10.1016/S0899-9007(01)00672-4
  7. Dandona P, Aljada A, Bandyopadhyay A. 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25: 4-7. https://doi.org/10.1016/j.it.2003.10.013
  8. Hotamisligil GS. 2003. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 3: S53-S55.
  9. Berg AH, Scherer PE. 2005. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96: 939-949. https://doi.org/10.1161/01.RES.0000163635.62927.34
  10. Vetter ML, Faulconbridge LF, Webb VL, Wadden TA. 2010. Behavioral and pharmacologic therapies for obesity. Nat Rev Endocrinol 6: 578-588. https://doi.org/10.1038/nrendo.2010.121
  11. Bray GA, Ryan DH. 2012. Medical therapy for the patient with obesity. Circulation 125: 1695-1703. https://doi.org/10.1161/CIRCULATIONAHA.111.026567
  12. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. 2004. XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27: 155-161. https://doi.org/10.2337/diacare.27.1.155
  13. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. 2011. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 377: 1341-1352. https://doi.org/10.1016/S0140-6736(11)60205-5
  14. Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O'Rahilly S, Heisler LK. 2008. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149: 1323-1328. https://doi.org/10.1210/en.2007-1321
  15. Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK. 2002. Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J Agric Food Chem 50: 10-22. https://doi.org/10.1021/jf010753k
  16. Sullivan AC, Singh M, Srere PA, Glusker JP. 1977. Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase. J Biol Chem 252: 7583-7590.
  17. Van Itallie TB. 1978. Dietary fiber and obesity. Am J Clin Nutr 31: S43-S52. https://doi.org/10.1093/ajcn/31.10.S43
  18. Ministry of Food and Drug Safety. http://www.foodsafetykorea.go.kr:80/portal/board/boardDetail.do?menu_no=442&menu_grp=MENU_GRP02&bbs_no=bbs021&bbs_type_cd=04&list_img_use_yn=N&atch_file_posbl_yn=N&tag_use_ yn=N&meta_use_yn=N (accessed Jul 2014).
  19. Kim AR, Hwang YG, Lee JJ, Jung HO, Lee MY. 2011. Effects of Eriobotrya japonica Lindl. (Loquat) leaf ethanol extract on cholesterol and antioxidative activity in rats fed a high-fat/high-cholesterol diet. J Korean Soc Food Sci Nutr 40: 673-681. https://doi.org/10.3746/jkfn.2011.40.5.673
  20. Lee CK, Park SW, Chung HY, Young HS, Suh SS, Park KY. 1991. Mechanism of antitumor effect of ursolic acid from Eriobotrya japonica. J Korean Cancer Assoc 23: 206-210.
  21. Shimizu M, Fukumura H, Tsuji H, Tanaami S, Hayashi T, Morita N. 1986. Anti-inflammatory constituents of topically applied crude drugs. I. Constituents and anti-inflammatory effect of Eriobotrya japonica LINDL. Chem Pharm Bull 34: 2614-2617. https://doi.org/10.1248/cpb.34.2614
  22. Choi MJ, Jung HK, Jeong YS, Park SC, Hong JH. 2010. Anti-allergic activities of fermented Eriobotrya japonica and Saurus chinensis extracts in 2,4-dinitrochlorobezene-induced BALB/c mice. J Korean Soc Food Sci Nutr 39: 1611-1618. https://doi.org/10.3746/jkfn.2010.39.11.1611
  23. Jeong JC, Yoon CH, Jeong JC, Kim CH. 1997. Effect of Eriobotryae folium extract on glucokinase and hexokinase activities of alloxan-induced diabetes mellitus mice. Dongguk J Inst Oriental Med 6: 151-161.
  24. De Tommasi N, De Simone F, Cirino G, Cicala C, Pizza C. 1991. Hypoglycemic effects of sesquiterpene glycosides and polyhydroxylated triterpenoids of Eriobotrya japonica. Planta Med 57: 414-416. https://doi.org/10.1055/s-2006-960137
  25. Nishioka Y, Yoshioka S, Kusunose M, Cui T, Hamada A, Ono M, Miyamura M, Kyotani S. 2002. Effects of extract derived from Eriobotrya japonica on liver function improvement in rats. Biol Pharm Bull 25: 1053-1057. https://doi.org/10.1248/bpb.25.1053
  26. Bae D, Kim J, Na JR, Kim Y, Lee JY, Kim S. 2014. Anti-amnesic effect of Eriobotrya japonica leaf extract on scopolamine-induced memory impairment in rats. J Korean Soc Food Sci Nutr 43: 799-806. https://doi.org/10.3746/jkfn.2014.43.6.799
  27. Shih CC, Lin CH, Wu JB. 2010. Eriobotrya japonica improves hyperlipidemia and reverses insulin resistance in high-fat-fed mice. Phytother Res 24: 1769-1780. https://doi.org/10.1002/ptr.3143
  28. Haglund O, Luostarinen R, Wallin R, Wibell L, Saldeen T. 1991. The effects of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E. J Nutr 121: 165-169. https://doi.org/10.1093/jn/121.2.165
  29. Rosenfeld L. 1989. Lipoprotein analysis. Early methods in the diagnosis of atherosclerosis. Arch Pathol Lab Med 113: 1101-1110.
  30. Jayasooriya AP, Sakono M, Yukizaki C, Kawano M, Yamamoto K, Fukuda N. 2000. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J Ethnopharmacol 72: 331-336. https://doi.org/10.1016/S0378-8741(00)00259-2
  31. Kim HK. 2000. Obesity and fat metabolism. J Korean Soc Study Obes 9: 63-65.
  32. Park SH, Jang MJ, Hong JH, Rhee SJ, Choi KH, Park MR. 2007. Effects of mulberry leaf extract feeding on lipid status of rats fed high cholesterol diets. J Korean Soc Food Sci Nutr 36: 43-50. https://doi.org/10.3746/jkfn.2007.36.1.043
  33. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432. https://doi.org/10.1038/372425a0
  34. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. 2002. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297: 240-243. https://doi.org/10.1126/science.1071527
  35. Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395: 763-770. https://doi.org/10.1038/27376
  36. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. 1997. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377. https://doi.org/10.1038/38717

Cited by

  1. 와송이 고지방 식이로 유도된 비만 쥐의 간내 지질 및 항산화 대사에 미치는 영향 vol.47, pp.4, 2019, https://doi.org/10.4014/mbl.1908.08008
  2. Antioxidant Activities and Quality Characteristic of Jeung-Pyun with the Addition of Loquat Leaf Powder vol.50, pp.10, 2021, https://doi.org/10.3746/jkfn.2021.50.10.1065